FCM
NVO

Fortis Capital Management’s Novo Nordisk NVO Stock Holding History

Fortis Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,850
Closed -$658K – 214
2025
Q3 		$658K Sell
11,850
-42,870
-78% -$2.51M 0.09% 98
2025
Q2 		$3.78M Sell
54,720
-468
-0.8% -$31.8K 0.59% 46
2025
Q1 		$3.83M Buy
55,188
+9,300
+20% +$768K 0.75% 44
2024
Q4 		$3.95M Buy
45,888
+11,039
+32% +$1.19M 0.73% 43
2024
Q3 		$4.15M Buy
34,849
+1,855
+6% +$247K 0.84% 36
2024
Q2 		$4.71M Buy
+32,994
New +$4.37M 1% 21

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fortis Capital Management's NVO Position: Q4 2025 in Review

Fortis Capital Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 11,850 shares — an estimated $658K sold.

Fortis Capital Management first reported a position in NVO in Q2 2024 and held it in 6 quarters. The position peaked at $4.71M in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Fortis Capital Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Fortis Capital Management sold 11,850 Novo Nordisk shares in Q4 2025, an estimated $658K.
  • Fortis Capital Management first reported a position in Novo Nordisk in Q2 2024 and held it in 6 quarters.
  • Fortis Capital Management's Novo Nordisk position peaked at $4.71M in Q2 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Fortis Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.